SOSTDC1-156 CTNND1-211 CLDND1-69 CCNG2-231 TFAM-231 TOP3B-628 MYBBP1A-1134 MYBBP1A-1306
HD Average 1730 2302 4518 2053 3374 1799 1739 2505
SD 442 884 2,329 492 2,882 367 433 676
Cut-off value 2,613 4,071 9,176 3,036 9,139 2,532 2,606 3,858
Total No. 111 111 111 111 111 111 111 111
Positive No. 5 6 5 5 1 5 6 3
Positive (%) 4.50% 5.40% 4.50% 4.50% 0.90% 4.50% 5.40% 2.70%
SLE Average 2,211 3,049 3,780 2,994 4,283 2,319 2,149 3,215
SD 968 2,992 2,606 5,308 4,169 2,321 1,974 3,101
Total No. 84 84 84 84 84 84 84 84
Positive No. 13 8 4 10 1 11 10 11
Positive (%) 15.50% 9.50% 4.80% 11.90% 1.20% 13.10% 11.90% 13.10%
P (vs HD) 0.000048 0.029 - 0.109 0.089 0.045 0.065 0.042
Table 3: Comparison of serum antibody levels between HD and SLE patients examined by AlphaLISA. Shown are average, SD, cut-off values (average + 2SD), total sample numbers, the number of positive sera of which the antibody levels were higher than the cut-off value, and the positive rate (%) of HD; average, SD, total sample number, number of positive sera of which the antibody levels were higher than the cut-off value, and the positive rate (%) of SLE patients; and P value of comparison between HD and SLE patients. P values lower than 0.05 and positive rates higher than 10% were marked in bold.